Skip to main content
. 2023 May 16;15(10):2783. doi: 10.3390/cancers15102783

Figure 5.

Figure 5

TP53 status determined using a combined ddPCR and NGS analysis in a subset of retrospective and prospective FFPE samples. TP53 mutation types (disruptive, inframe (IF)) in both deleted and not-deleted cases for the whole cohort (A) and for the three groups categorized according to the IHC staining level (B). The percentages of each mutation type are reported.